Table 3 Gene expression of IDO, CIITA and HLA-DR in MSCs of P2
MSC donors | 2,3-IDO ng/µL | CIITA ng/µL | HLA-DR % |
|---|---|---|---|
MSCs-310821-P2/PL-240 | ND | 46.9 | 6.9 |
MSCs-310821-P2/PL-240 + TGF-β1 | ND | 17.1 | 2.7 |
MSCs-310821-P2/PL-240 + IFN-γ | 50.9 | 95.6 | 58.3 |
MSCs-310821-P2/PL-240 + IFN-γ + TGF-β1 | 35.1 | 67.3 | 40.1 |
MSCs-181116-P2/PL-269 | ND | 55.8 | a6.3 |
MSCs-181116-P2/PL-269 + TGF-β1 | ND | 16.1 | 4.9 |
MSCs-181116-P2/PL-269 + IFN-γ | 42.6 | 74.8 | 95.4 |
MSCs-181116-P2/PL-269 + IFN-γ + TGF-β1 | 36.9 | 64.5 | 93.4 |
MSCs-220922-P2/PL-269 | 1.4 | 55.2 | 29.5 |
MSCs-220922-P2/PL-269 + TGF-β1 | ND | 36.8 | 33.6 |
MSCs-220922-P2/PL-269 + IFN-γ | 52.0 | 76.9 | 91.2 |
MSCs-220922-P2/PL-269 + IFN-γ + TGF-β1 | 42.9 | 62.5 | 90.3 |